53. Ghosh S., Banerjee S., Sil P. C. (2015), "The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update", Food and Chemical Toxicology, 83, pp. 111-124.
54. Gibson F. S., Bergmeier S. C., Rapoport H. (1994), "Selective removal of an N-BOC protecting group in the presence of a tert-butyl ester and other acid- sensitive groups", The Journal of Organic Chemistry, 59(11), pp. 3216-3218.
55. Gibson M. (2009), Pharmaceutical Preformulation And Formulation; Chapter 2: Aiding Candidate Drug Selection: Introduction and Objectives, Boca Raton, pp. 11-16.
56. Giner R. M., Villalba M. L., Recio M. C., Máđez S., Cerdá-Nicolás M., Rı́os
J. L. (2000), "Anti-inflammatory glycoterpenoids from Scrophularia auriculata", European Journal of Pharmacology, 389(2-3), pp. 243-252.
57. Guduru S. K. R., Arya P. (2018), "Synthesis and biological evaluation of rapamycin-derived, next generation small molecules", Medchemcomm, 9(1), pp. 27-43.
58. Gupta N. K., Nahata A., Dixit V. K. (2010), "Development of a spectrofluorimetric method for the determination of curcumin", Asian Journal of Traditional Medicines, 5(1), pp. 12-18.
59. Halgren T. A., Murphy R. B., Friesner R. A., Beard H. S., Frye L. L., Pollard
W. T., Banks J. L. (2004), "Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening", Journal of Medicinal Chemistry, 47(7), pp. 1750-1759.
60. Han H., de Vrueh R. L. A., Rhie J. K., Covitz K. M. Y., Smith P. L., Lee C. P., Oh D. M., Sadee W., Amidon G. L. (1998), "5Ɵ-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter", Pharmaceutical Research, 15(8), pp. 1154-1159.
Có thể bạn quan tâm!
-
Cấu Trúc Ph12 Và Các Giá Trị Tín Hiệu Proton, Carbon Trong Phân Tử Trên Phổ Nmr -
Bàn Luận Về Dẫn Chất Tiềm Năng Mono-O-(2- (Succinyloxy)Ethyl)Curcumin (Ph9) -
Nghiên cứu bán tổng hợp một số dẫn chất curcumin nhằm cải thiện độ tan trong nước hướng ứng dụng trong dược phẩm - 24 -
Phổ Phổ Esi-Ms-Negative Của Sản Phẩm Thủy Phân Ph1, -
Phổ Ir Của Chất Ph9 Thu Được Ở Quy Mô 20 G/mẻ Pl-116 -
Phổ Esi-Ms-Positive Của Chất Ph2
Xem toàn bộ 442 trang tài liệu này.
61. Handler N., Jaeger W., Puschacher H., Leisser K., Erker T. (2007), "Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase- 1 (COX-1) inhibitors", Chemical and Pharmaceutical Bulletin, 55(1), pp. 64- 71.
62. Harteneck C. (2013), "Pregnenolone sulfate: from steroid metabolite to TRP channel ligand", Molecules, 18(10), pp. 12012-12028.
63. Hatamie S., Nouri M., Karandikar S. K., Kulkarni A., Dhole S. D., Phase D. M., Kale S. N. (2012), "Complexes of cobalt nanoparticles and polyfunctional
curcumin as antimicrobial agents", Materials Science and Engineering: C, 32(2), pp. 92-97.
64. Heger M., van Golen R. F., Broekgaarden M., Michel M. C. (2014), "The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer", Pharmacological Reviews, 66(1), pp. 222-307.
65. Hergenhahn M., Bertram B., Wiessler M., Sorg B. L. (2001), "Saccharide- contaning curcumin derivatives with improved water solubility for pharmaceuticals", German Patents, DE2337.
66. Hill C. A. S., Papadopoulos A. N. (2002), "The pyridine-catalysed acylation of pine sapwood and phenolic model compounds with carboxylic acid anhydrides. Determination of activation energies and entropy of activation", Holzforschung, 56, pp. 150-156.
67. Hoehle S. I., Pfeiffer E., Solyom A. M., Metzler M., (2006), "Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver", Journal of Agricultural and Food Chemistry, 54, pp. 756-764.
68. Hoiberg C. P., Mumma R. O. (1969), "Preparation of sulfate esters. Reactions of various alcohols, phenols, amines, mercaptans, and oximes with sulfuric acid and dicyclohexylcarbodiimide", Journal of the American Chemical Society, 91(15), pp. 4273-4278.
69. Hu L., Jia Y., Niu F., Jia Z., Yang X., Jiao K. (2012), "Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle", Journal of Agricultural and Food Chemistry, 60(29), pp. 7137-7141.
70. Huang T., Wu P., Cheng A., Qin J., Zhang K., Zhao S. (2015), "A hydrophilic conjugate approach toward the design and synthesis of ursolic acid derivatives as potential antidiabetic agent", RSC Advances, 5(55), pp. 44234-44246.
71. Isidro-Llobet A., Alvarez M., Albericio F. (2009), "Amino acid-protecting groups", Chemical Reviews, 109(6), pp. 2455-2504.
72. Jacob J. N., Badyal D. K., Bala S., Toloue M. (2013), "Evaluation of the in vivo anti-inflammatory and analgesic and in vitro anti-cancer activities of curcumin and its derivatives", Natural Product Communications, 8(3), p. 1934578X1300800321.
73. Jasim F., Ali F. (1989), "Measurements of some spectrophotometric parameters of curcumin in 12 polar and nonpolar organic solvents", Microchemical Journal, 39(2), pp. 156-159.
74. Jasim F., Ali F. (1988), "A novel method for the spectrophotometric determination of curcumin and its application to curcumin spices", Microchemical Journal, 38(1), pp. 106-110.
75. Ji H., Tang J., Li M., Ren J., Zheng N., Wu L. (2016), "Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin", Drug Delivery, 23(2), pp. 459- 470.
76. Jornada D. H., Fernandes G. F. D. S., Chiba D. E., Ferreira De Melo T. R., Leandro Dos Santos J., Chung M. C. (2016), "The prodrug approach: A successful tool for improving drug solubility", Molecules, 21(1), p. 42.
77. Joseph E., Hanley P. G. (1960), "Preparation of steroidal 21-phosphate derivatives", United States Patents, US2936313A.
78. Jung Y. J., Doh M. J., Kim I. H., Kong H. S., Lee J. S., Kim Y. M. (2003), "Prednisolone 21‐sulfate sodium: a colon‐specific pro‐drug of prednisolone", Journal of Pharmacy and Pharmacology, 55(8), pp. 1075-1082.
79. Kaczor T. (2011), "Alpha tocopheryl succinate in cancer care. Just another vitamin E", Nature Medicine 3(6).
80. Kanhathaisong S., Rattanaphani S., Rattanaphani V., Manyum T. (2011), "A spectroscopic investigation of the complex of turmeric dye with copper (II) in aqueous solution", Suranaree Journal of Science and Technology, 18(2), pp. 159-165.
81. Karioti A., Fani E., Vincieri F. F., Bilia A. R. (2011), "Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC–ESI-MS", Journal of Pharmaceutical and Biomedical Analysis, 55(3), pp. 479-486.
82. Kedare S. B., Singh R. P. (2011), "Genesis and development of DPPH method of antioxidant assay", Journal of Food Science and Technology, 48(4), pp. 412-422.
83. Khan M. A., El-Khatib R., Rainsford K. D., Whitehouse M. W. (2012), "Synthesis and anti-inflammatory properties of some aromatic and heterocyclic aromatic curcuminoids", Bioorganic Chemistry, 40, pp. 30-38.
84. Khopde V. (1999), "Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue", Biophysical Chemistry, 80, pp. 85- 91.
85. Khurana A., Ho C. T. (1988), "High performance liquid chromatographic analysis of curcuminoids and their photo-oxidative decomposition compounds in Curcuma longa L", Journal of Liquid Chromatography, 11(11), pp. 2295- 2304.
86. Kim H., Lee Y., Yoo H., Kim J., Kong H., Yoon J., Jung Y., Kim Y. M. (2012), "Synthesis and evaluation of sulfate conjugated metronidazole as a colon- specific prodrug of metronidazole", Journal of Drug Targeting, 20(3), pp. 255-263.
87. Kim M. K., Mok H., Chong Y. (2012), "Increased Water Solubility of the Curcumin Derivatives via Substitution with an Acetoxy Group at the Central Methylene Moiety", Bulletin of the Korean Chemical Society, 33(9), pp. 2849- 2850.
88. Kiuchi F. (1993), "Nematocidal Activity of Turmeric: Synergistic Action of Curcuminoids “", Chemical and Pharmaceutical Bulletin, 41(9), pp. 1640- 1643.
89. Kopáni M. (2006), "Oxidative stress and electron spin resonance", Clinica Chimica Acta, 364(1), pp. 61-66.
90. Kumar A., Ahuja A., Ali J., Baboota S. (2016), "Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells", Drug Delivery, 23(1), pp. 214-229.
91. Lao C. D., Ruffin M. T., Normolle D., Heath D. D., Murray S., Bailey J. M., Boggs M. E., Crowell J., Rock C. L., Brenner D. E. (2006), "Dose escalation of a curcuminoid formulation", BMC Complementary and Alternative Medicine, 6(1), pp. 1-4.
92. Li J., Shin G. H., Chen X., Park H. J. (2015), "Modified curcumin with hyaluronic acid: combination of pro-drug and nano-micelle strategy to address the curcumin challenge", Food Research International, 69, pp. 202-208.
93. Li R., Qiao X., Li Q., He R., Ye M., Xiang C., Lin X., Guo D. (2011), "Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of
nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry", Journal of Chromatography B, 879(26), pp. 2751-2758.
94. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. (1997), "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings", Advanced Drug Delivery Reviews, 23(1-3), pp. 3-25.
95. Litwinienko G., Ingold K. U. (2004), "Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer", The Journal of Organic Chemistry, 69(18), pp. 5888-5896.
96. Liu K., Zhang D., Chojnacki J., Du Y., Fu H., Grantd S., Zhang S. (2013), "Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma", Organic & Biomolecular Chemistry, 11(29), pp. 4757-4763.
97. Luo Xuan‐De, Shen Chia‐Chiang (1987), "The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives", Medicinal Research Reviews, 7(1), pp. 29-52.
98. Majeed M., Prakash L. (2008), "Tetrahydrocurcuminoids CG: Bioactive antioxidant compounds from curcuminoids", Sabinsa Corporation.
99. Manju S., Sreenivasan K. (2011), "Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability", Journal of Colloid and Interface Science, 359(1), pp. 318-325.
100. Marvel C. S., Sparberg M.S. (2003), "Sodium 2‐Bromoethanesulfonate: Ethanesulfonic acid, 2‐bromo‐, sodium salt", Organic Syntheses, 10, pp. 96- 96.
101. Mawani Y., C. Orvig (2014), "Improved separation of the curcuminoids, syntheses of their rare earth complexes, and studies of potential antiosteoporotic activity", Journal of Inorganic Biochemistry, 132, pp. 52-58.
102. Mazumder A., Neamati N., Sunder S., Schulz J., Pertz H., Eich E., Pommier
Y. (1997), "Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action", Journal of Medicinal Chemistry, 40(19), pp. 3057-3063.
103. Menon V. P., Sudheer A. R. (2007), The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer, Boston, MA.
104. Merck & Co. Inc. (2008), The Merck Index 14th ed., Whitehouse Station, NJ, USA.
105. Miki T., Hiraga K., Masuya H., Asako T., Fujii S., Kawai K., Kikuchi K., Shintani S., Yamazaki M. (1974), "A Phosphorylation of Steroids and a Dienone-Phenol Rearrangement leading to a Secosteroidal Aldehyde Which has a Strong Toxicity", Chemical and Pharmaceutical Bulletin, 22(7), pp. 1439-1450.
106. Mishra R., Pandey S., Trivedi S., Pandey S., Pandey P. S. (2014), "Synthesis and properties of L-valine based chiral long alkyl chain appended 1, 2, 3- triazolium ionic liquids", RSC Advances, 4(63), pp. 33478-33488.
107. Mishra S., Kapoor N., Ali A. M., Pardhasaradhi B.V.V., Kumari A. L., Khar A., Misra K. (2005), "Differential apoptotic and redox regulatory activities of curcumin and its derivatives", Free Radical Biology and Medicine, 38(10), pp. 1353-1360.
108. Mishra S., Narain U., Mishra R., Misra K. (2005), "Design, development and synthesis of mixed bioconjugates of piperic acid–glycine, curcumin– glycine/alanine and curcumin–glycine–piperic acid and their antibacterial and antifungal properties", Bioorganic & Medicinal Chemistry, 13(5), pp. 1477- 1486.
109. Mitra S. P. (2007), "Binding and stability of curcumin in presence of bovine serum albumin", Journal of Surface Science and Technology, 23(3/4), pp. 91- 110.
110. Mohri K., Watanabe Y., Yoshida Y., Satoh M., Isobe K., Sugimoto N., Tsuda
Y. (2003), "Synthesis of glycosylcurcuminoids", Chemical and Pharmaceutical Bulletin, 51(11), pp. 1268-1272.
111. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A. (1991), "Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines", JNCI: Journal of the National Cancer Institute, 83(11), pp. 757-766.
112. Mosmann T. (1983), "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", Journal of Immunological Methods, 65(1-2), pp. 55-63.
113. Muangnoi C., Jithavech P., Ratnatilaka Na Bhuket P., Supasena W., Wichitnithad W., Towiwat P., Niwattisaiwong N., Haworth I. S., Rojsitthisak
P. (2018), "A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin", Bioscience, Biotechnology, and Biochemistry, 82(8), pp. 1301-1308.
114. Muegge I., Heald S. L., Brittelli D. (2001), "Simple selection criteria for drug- like chemical matter", Journal of Medicinal Chemistry, 44(12), pp. 1841- 1846.
115. Mumma R. O. (1966), "Preparation of sulfate esters", Lipids, 1(3), pp. 221- 223.
116. Nakamura Y., Ohto Y., Murakami A., Osawa T., Ohigashi H. (1998), "Inhibitory effects of curcumin and Tetrahydrocurcuminoids on the tumor- promoter-induced reactive oxygen species generation in leukocytes, in vitro and in vivo", Japanese Journal of Cancer Research, 89(4), pp. 361-370.
117. Nelson K. M., Dahlin J. L., Bisson J., Graham J., Pauli G. F., Walters M. A. (2017), "The essential medicinal chemistry of curcumin: miniperspective", Journal of Medicinal Chemistry, 60(5), pp. 1620-1637.
118. Oetari S., Sudibyo M., Commandeur J. N. M., Samhoedi R., Vermeulen N. P.
E. (1996), "Effects of curcumin on cytochrome P450 and glutathione S- transferase activities in rat liver", Biochemical Pharmacology, 51(1), pp. 39- 45.
119. Ohtsu H. (2002), "Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents", Journal of Medicinal Chemistry, 45(23), pp. 5037-5042.
120. Organization for Economic Cooperation and Development, OECD guidelinesfor testing of chemicals. Section 4, health effects: Test No. 425: Acute oral toxicity: Up–and–down procedure. 2008: OECD (Organization for Economic Cooperation and Development).
121. Organization for Economic Cooperation and Development, OECD guidelinesfor testing of chemicals. Section 4, health effects: Test No. 423: Acute Oral Toxicity-Acute Toxic Class Method. 2002: OECD (Organization for Economic Cooperation and Development).
122. Organization for Economic Cooperation and Development, OECD guidelinesfor testing of chemicals,Test No.107: Partition coefficient (n- octanol/water): Shake flask method. 1995: OECD (Organization for Economic Cooperation and Development).
123. Osawa T., Sugiyama Y., Inayoshi M., Kawakishi S. (1995), "Antioxidative activity of tetrahydrocurcuminoids", Bioscience, Biotechnology, and Biochemistry, 59(9), pp. 1609-1612.
124. Pacheco N. R., Pinto N. C. C., Mello da Silva J., Mendes R. F., Costa J. C., Aragão D. M. O.,Castađon M. C. M. N., Scio E. (2014), "Cecropia pachystachya: a species with expressive in vivo topical anti-inflammatory and in vitro antioxidant effects", BioMed Research International, 2014.
125. Pandey M. K., Kumar S., Thimmulappa R. K., Parmar V. S., Biswal S., Watterson A. C. (2011), "Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells", European Journal of Pharmaceutical Sciences, 43(1-2), pp. 16-24.
126. Pant M. K., Panthari P., Kharkwal A., Kharkwal H., Kharkwal H. (2014), "Curcumin: A wonder therapeutical drug", World Journal of Pharmacy and Pharmaceutical Sciences, 3(6), pp. 374-396.
127. Parvathy K. S. (2009), Chemical approaches toward preparation of water- soluble curcumin derivatives, University of Mysore.
128. Parvathy K. S., Negi P. S., Srinivas P. (2010), "Curcumin–amino acid conjugates: Synthesis, antioxidant and antimutagenic attributes", Food chemistry, 120(2), pp. 523-530.
129. Pasqualini JR, Gelly C, Nguyen B-L, Vella C. (1989), "Importance of estrogen sulfates in breast cancer", Journal of Steroid Biochemistry, 34(1-6), pp. 155- 163.
130. Patnaik P. (2003), Handbook of inorganic chemicals, McGraw-Hill New York.
131. Perino S., Contino-Pépin C., Satchi-Fainaro R., Butterfield C., Pucci B. (2004), "Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties", Bioorganic & Medicinal Chemistry Letters, 14(2), pp. 421-425.
132. Power M., Martin D. (2005), "Pharmaceutical salts of 3-O-(3', 3'- dimethylsuccinyl) betulinic acid", United State Patents, US20050239748A1.
133. Prasad K. N., Kumar B., Yan X. D., Hanson A. J., Cole W. C. (2003), "ŀ- tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review", Journal of the American College of Nutrition, 22(2), pp. 108-117.